Psychedelics biotech Clearmind Medicine Inc. (NASDAQ: CMND) has successfully completed two drug discovery projects with leading scientists at the Hebrew University of Jerusalem.

The projects are part of a collaboration with technology transfer company Yissum, a business partner of renowned firms like Boston Scientific (NYSE: BSX), ICL (NYSE: ICL), Intel (NASDAQ: INTC), Johnson & Johnson (NYSE: JNJ), Merck (NYSE: MRK) …

Full story available on Benzinga.com